Evidence map›Paper›PMID 33859366›Full record

ArticlePediatric research2022

Molecular regulation of lung maturation in near-term fetal sheep by maternal daily vitamin C treatment in late gestation.

Erin V McGillick, Sandra Orgeig, Beth J Allison, Kirsty L Brain, Youguo Niu, Nozomi Itani, Katie L Skeffington, Andrew D Kane, Emilio A Herrera, Janna L Morrison and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Pediatric research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Ascorbic acid intake during pregnancy.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2023
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Erin V McGillickEarly Origins of Adult Health Research Group, Health and Biomedical Innovation, University of South Australia, Adelaide, SA, Australia.
Sandra OrgeigMolecular and Evolutionary Physiology of the Lung Laboratory, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Beth J AllisonDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridgeshire, UK.
Kirsty L BrainDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridgeshire, UK.
Youguo NiuDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridgeshire, UK.
Nozomi ItaniDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridgeshire, UK.
Katie L SkeffingtonDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridgeshire, UK.
Andrew D KaneDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridgeshire, UK.
Emilio A HerreraPrograma de Fisiopatología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Janna L MorrisonEarly Origins of Adult Health Research Group, Health and Biomedical Innovation, University of South Australia, Adelaide, SA, Australia.
Dino A GiussaniDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridgeshire, UK. dag26@cam.ac.uk.
University of Cambridge · GBUniversity of South Australia · AUUniversity of Chile · CL

Funding

British Heart Foundation RG/06/006/22028British Heart Foundation RG/17/8/32924
6 · The paper itself

Abstract

backgroundIn the fetus, the appropriate balance of prooxidants and antioxidants is essential to negate the detrimental effects of oxidative stress on lung maturation. Antioxidants improve respiratory function in postnatal life and adulthood. However, the outcomes and biological mechanisms of antioxidant action in the fetal lung are unknown.

methodsWe investigated the effect of maternal daily vitamin C treatment (200 mg/kg, intravenously) for a month in late gestation (105-138 days gestation, term ~145 days) on molecular regulation of fetal lung maturation in sheep. Expression of genes and proteins regulating lung development was quantified in fetal lung tissue. The number of surfactant-producing cells was determined by immunohistochemistry.

resultsMaternal vitamin C treatment increased fetal lung gene expression of the antioxidant enzyme SOD-1, hypoxia signaling genes (HIF-2α, HIF-3α, ADM, and EGLN-3), genes regulating sodium movement (SCNN1-A, SCNN1-B, ATP1-A1, and ATP1-B1), surfactant maturation (SFTP-B and ABCA3), and airway remodeling (ELN). There was no effect of maternal vitamin C treatment on the expression of protein markers evaluated or on the number of surfactant protein-producing cells in fetal lung tissue.

conclusionsMaternal vitamin C treatment in the last third of pregnancy in sheep acts at the molecular level to increase the expression of genes that are important for fetal lung maturation in a healthy pregnancy. IMPACT: Maternal daily vitamin C treatment for a month in late gestation in sheep increases the expression of gene-regulating pathways that are essential for normal fetal lung development. Following late gestation vitamin C exposure in a healthy pregnancy, an increase in lung gene but not protein expression may act as a mechanism to aid in the preparation for exposure to the air-breathing environment after birth. In the future, the availability/development of compounds with greater antioxidant properties than vitamin C or more specific targets at the site of oxidative stress in vivo may translate clinically to improve respiratory outcomes in complicated pregnancies at birth.

Indexed as

AntioxidantsPulmonary SurfactantsAdultAnimalsAscorbic AcidFemaleFetusHumansLungPregnancySheepSurface-Active AgentsAntioxidantsAscorbic AcidPulmonary SurfactantsSurface-Active Agents

Identifiers

PMID33859366
PMCPMC9064793
OpenAlexW3155290387

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.